Acadia Pharmaceuticals | Caixa E Equivalentes

Created with Highcharts 10.1.0Chart context menu


Cash And Equivalent Alterar Data
Acadia Pharmaceuticals USD 755.99M 190.66M 2024-12
ALKERMES USD 291.15M 636.63M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Biogen USD 2.38B 675.8M 2024-12
BioMarin Pharmaceutical USD 613.22M 324.54M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Cytokinetics USD 94.86M 47.97M 2024-12
Eisai JPY 291.26B 22.65B 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Incyte USD 1.69B 383.72M 2024-12
J&J USD 6.12B 1.28B 2024-12
Moderna USD 1.93B 283M 2024-12
Neurocrine Biosciences USD 233M 116.1M 2024-12
Pfizer USD 1.04B 49M 2024-12
Prothena USD 471.39M 47.87M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Acadia Pharmaceuticals Caixa E Equivalentes - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.